Not All Sleep Apnea Is the Same: Why OSA Phenotypes Matter for Treatment
Two patients with the identical AHI can have completely different symptoms, heart-disease risk, and response to treatment — here's why researchers now describe sleep apnea in terms of phenotypes rather than one number...

By Dr. Boris Zusin · Published September 8, 2026
Your AHI (apnea-hypopnea index) is the number that gets the most attention after a sleep study, but two people with the exact same AHI can look nothing alike clinically — different symptoms, different heart-disease risk, and different odds of responding to any given treatment. (For patients whose sleep study looks essentially normal despite daytime symptoms, a related condition worth knowing about is upper airway resistance syndrome.) That mismatch is exactly why sleep researchers have moved toward describing obstructive sleep apnea (OSA) in terms of "phenotypes" rather than a single severity number. The goal isn't just academic: matching treatment to the specific traits driving an individual's disease, rather than treating every case of "moderate OSA" the same way, is the whole idea behind precision medicine applied to sleep apnea.
Clinical Phenotypes: Not Everyone With OSA Feels the Same
Studies that cluster patients by their symptoms — independent of their AHI — consistently find three recognizable groups. An excessively sleepy group has pronounced daytime sleepiness and gets the clearest symptomatic benefit from CPAP or an oral appliance, but this group also carries a notably higher cardiovascular risk (roughly 1.7 to 2.4 times higher risk of a future cardiovascular event) than other OSA patients with the same AHI — a striking finding, since it means the symptom pattern itself is flagging something the AHI number alone misses. A disturbed sleep group has prominent insomnia-type complaints and, in one well-studied cohort, still had residual insomnia symptoms even after effective airway treatment — suggesting the insomnia component often needs its own targeted treatment alongside, not instead of, OSA therapy. A third, minimally symptomatic group has few daytime complaints at all and tends to see less symptomatic benefit from treatment, at least by the usual measures of "success."
What Routine Sleep Studies Miss Beyond the AHI Number
Even within a standard sleep study, several other measurements turn out to matter more for long-term risk than the AHI itself: how much and how long oxygen levels drop (hypoxic burden and time spent below 90% oxygen saturation), how events are distributed between REM and non-REM sleep — a pattern we cover in more depth in our piece on REM-predominant sleep apnea — and whether apnea is markedly worse lying on the back (positional OSA, generally defined as at least twice the event rate on the back compared to other positions). This is part of why some large trials selecting patients purely by AHI have found disappointingly little cardiovascular benefit from treatment — AHI alone doesn't capture how much oxygen-level stress a given patient's disease is actually causing. Positional OSA in particular is a distinct, separately treatable pattern; see our page on sleep position and snoring/apnea for more on that specific approach.
Anatomic and Craniofacial Phenotypes: Where Dental Evaluation Comes In
This is the phenotype domain most directly relevant to what we evaluate at a dental sleep visit. Research consistently finds certain airway and jaw traits more often in OSA patients: a narrower pharyngeal airway, a hyoid bone (the small U-shaped bone that anchors tongue and airway muscles) sitting lower than typical, increased lower-face height, a retruded or underdeveloped lower jaw, and shorter jaw lengths overall. When researchers cluster patients by combining OSA severity, body weight, and these craniofacial traits, distinct groups emerge: an obesity-predominant type where excess weight is the main driver, a skeletal type (often a retruded upper and lower jaw with a steep, "high-angle" facial pattern) in patients who aren't obese at all, and a complex type combining both obesity and unfavorable jaw anatomy along with a displaced hyoid. These aren't just academic categories — they point toward different management priorities: weight-directed care for the obesity-predominant type, and orthodontic, oral appliance, or surgical approaches that specifically address jaw anatomy for the skeletal type.
The Physiologic "PALM" Traits
Underneath the clinical and anatomic patterns above, researchers also describe four physiologic traits that can combine in any individual patient and are sometimes called by the acronym PALM:
- Pharyngeal anatomy/collapsibility — how prone the airway is to collapsing on its own, independent of everything else (this is the trait a MAD and most dental therapy directly target).
- Arousal threshold — how easily a person wakes from a partial obstruction; a low threshold means waking up before the body has a chance to stabilize breathing on its own, which paradoxically can worsen events.
- Loop gain — how unstable a person's breathing control system is; high loop gain drives a pattern of overcorrection that perpetuates repeated events.
- Upper-airway muscle responsiveness — how well the tongue and throat muscles activate to keep the airway open during sleep.
These traits matter because they explain why treatments that have nothing to do with jaw position can still work well for the right patient — a sedative-type medication for a low arousal threshold, supplemental oxygen or a medication like acetazolamide for high loop gain, or hypoglossal nerve stimulation (an implanted device that directly stimulates the nerve controlling tongue muscle tone) for poor muscle responsiveness. These are medical or surgical options managed by a sleep physician or ENT, not something provided at a dental sleep visit, but understanding that they exist helps explain why "just try CPAP or a MAD" isn't always the full answer for every patient.
Tying It Back to Oral Appliance Candidacy
The anatomic and physiologic phenotypes above are exactly what underlies the predictors discussed on our who responds best to a MAD page. Two additional studies reinforce that same finding from a slightly different angle: identifying an obstruction pattern centered at the base of the tongue on drug-induced sleep endoscopy (DISE), rather than a full circular collapse at the level of the palate or a side-to-side collapse pattern, meaningfully improves how well clinicians can predict who will actually respond to an oral appliance before treatment even starts. This is a big part of why a thorough dental sleep evaluation looks at more than just your AHI number — the anatomic pattern behind that number is what actually determines whether a given approach is likely to work for you.
An Honest Limitation
Phenotyping is a genuinely useful way to think about OSA, but it isn't yet a finished, standardized system you can look up in a table. Different studies define their clusters somewhat differently, most of the underlying research still needs prospective validation (confirming that sorting patients by phenotype up front actually improves outcomes, not just that the patterns exist after the fact), and much of the existing data underrepresents women and non-white populations. In practice, that means phenotyping is best used the way we use it here: as a framework for understanding why your specific case might respond differently than a friend's or family member's with a similar-sounding diagnosis, not as a rigid formula for treatment.
If you've been told you have OSA and are trying to understand why your particular case is being approached the way it is — or why a treatment that worked for someone else didn't work for you — that's exactly the kind of conversation worth having at a sleep evaluation.
Sources
- Phenotypic Subtypes of OSA: A Challenge and Opportunity for Precision Medicine — Zinchuk A, Yaggi HK, Chest (2020)
- Phenotyping Obstructive Sleep Apnea: A Pathway to Precision Medicine — BaHammam AS, Sleep & Breathing (2026)
- Treatment Options in Obstructive Sleep Apnea — Gambino F, Zammuto MM, Virzì A, Conti G, Bonsignore MR, Internal and Emergency Medicine (2022)
- Changing Faces of Obstructive Sleep Apnea: Treatment Effects by Cluster Designation in the Icelandic Sleep Apnea Cohort — Pien GW, Ye L, Keenan BT, et al., Sleep (2018)
- Diagnosis and Management of Obstructive Sleep Apnea — Gottlieb DJ, Punjabi NM, The Journal of the American Medical Association (2020)
- Craniofacial and Upper Airway Morphology in Adult Obstructive Sleep Apnea Patients: A Systematic Review and Meta-Analysis of Cephalometric Studies — Neelapu BC, Kharbanda OP, Sardana HK, et al., Sleep Medicine Reviews (2017)
- Craniofacial Risk Factors for Obstructive Sleep Apnea — Systematic Review and Meta-Analysis — Finke H, Drews A, Engel C, Koos B, Journal of Sleep Research (2024)
- Clustering-Based Characterization of Clinical Phenotypes in Obstructive Sleep Apnoea Using Severity, Obesity, and Craniofacial Pattern — An HJ, Baek SH, Kim SW, Kim SJ, Park YG, European Journal of Orthodontics (2020)
- Multi-Perspective Clustering of Obstructive Sleep Apnea Towards Precision Therapeutic Decision Including Craniofacial Intervention — Kim SJ, Alnakhli WM, Alfaraj AS, et al., Sleep & Breathing (2021)
- Multimodal Phenotypic Labelling Using Drug-Induced Sleep Endoscopy, Awake Nasendoscopy and Computational Fluid Dynamics for the Prediction of Mandibular Advancement Device Treatment Outcome: A Prospective Study — Van den Bossche K, Op de Beeck S, Dieltjens M, et al., Journal of Sleep Research (2022)
- Phenotypic Labelling Using Drug-Induced Sleep Endoscopy Improves Patient Selection for Mandibular Advancement Device Outcome: A Prospective Study — Op de Beeck S, Dieltjens M, Verbruggen AE, et al., Journal of Clinical Sleep Medicine (2019)
Related to This Article
Have a Dental Question of Your Own?
Reach out and we'll help you find the right next step.
Schedule Your Visit Call 212-877-7475